Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma I: Introduction01:28

Asthma I: Introduction

112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of a genetic risk factor for metformin-induced vitamin B<sub>12</sub> deficiency.

Diabetologia·2026
Same author

Cytotoxicity Modulated by Cyanotoxins in Neuroblastoma SH-SY5Y Cells.

Journal of Experimental Pathology·2025
Same author

XBP1 expression in pancreatic islet cells is associated with poor glycaemic control especially in young non-obese onset diabetes across ancestries.

Communications medicine·2025
Same author

Childhood Allergy and Neurodivergence: A Cross-Sectional Analysis in a UK-Birth Cohort.

Allergy·2025
Same author

Polygenic prediction of body mass index and obesity through the life course and across ancestries.

Nature medicine·2025
Same author

Microcystin: From Blooms to Brain Toxicity.

Journal of cellular signaling·2025

Related Experiment Video

Updated: May 5, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K

A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current

Roger Tavendale1, Donald F Macgregor, Somnath Mukhopadhyay

  • 1Population Pharmacogenetics Group, Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom.

The Journal of Allergy and Clinical Immunology
|April 9, 2008
PubMed
Summary

Genetic variations near the ORMDL3 gene increase childhood asthma risk and worsen asthma control in young patients. This finding highlights a key genetic factor in pediatric asthma development and severity.

More Related Videos

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

46.4K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Related Experiment Videos

Last Updated: May 5, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K
Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

46.4K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Area of Science:

  • Genetics
  • Pediatric Asthma Research
  • Molecular Biology

Background:

  • Childhood asthma genetics remain poorly understood.
  • Previous studies suggested single nucleotide polymorphisms (SNPs) near ORMDL3, NRG1, and ERO1LB genes are significant.
  • Identifying genetic markers is crucial for understanding asthma etiology.

Purpose of the Study:

  • To validate associations between specific genetic markers and asthma in a Scottish population.
  • To evaluate the impact of these variants on asthma exacerbations.
  • To investigate the role of ORMDL3, NRG1, and ERO1LB gene loci in childhood asthma.

Main Methods:

  • Case-control study involving 1054 asthmatic patients (ages 3-22).
  • DNA collected via mouthwash for genotyping.
  • Clinical interviews and measurements used to assess asthma susceptibility and exacerbations.
  • Analysis of three SNPs in candidate genes: ORMDL3 (rs7216389), NRG1 (rs4512342), and ERO1LB (rs10924993).

Main Results:

  • A common C/T polymorphism in ORMDL3 (rs7216389) strongly associated with childhood asthma risk (P = 1.73 x 10(-12)).
  • The T allele of rs7216389 conferred increased odds of asthma (OR=1.50 for one copy, OR=2.11 for two copies).
  • In asthmatic patients, the T allele of rs7216389 was linked to increased exacerbations (P = .008).
  • SNPs in NRG1 and ERO1LB showed no significant association with asthma occurrence or exacerbations.

Conclusions:

  • Genetic variation at the ORMDL3 locus significantly increases susceptibility to childhood asthma.
  • This genetic factor is associated with poorer asthma control in children and young adults.
  • The ORMDL3 locus is a critical genetic determinant in pediatric asthma.